| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 136.51B | 142.38B | 155.50B | 142.61B | 111.24B | 98.99B |
| Gross Profit | 20.75B | 30.54B | 29.69B | 24.57B | 21.99B | 13.58B |
| EBITDA | 19.16B | 20.16B | 26.73B | 32.39B | 21.25B | 10.67B |
| Net Income | 5.74B | 7.29B | 11.29B | 17.94B | 12.38B | 3.77B |
Balance Sheet | ||||||
| Total Assets | 259.71B | 267.73B | 250.89B | 246.93B | 229.53B | 216.66B |
| Cash, Cash Equivalents and Short-Term Investments | 21.11B | 21.85B | 17.33B | 22.03B | 21.81B | 18.64B |
| Total Debt | 106.34B | 85.50B | 71.55B | 71.56B | 83.73B | 87.58B |
| Total Liabilities | 165.76B | 172.73B | 157.97B | 155.64B | 154.40B | 155.14B |
| Stockholders Equity | 91.79B | 92.31B | 89.60B | 87.13B | 74.37B | 60.89B |
Cash Flow | ||||||
| Free Cash Flow | -2.95B | -4.64B | 6.47B | 14.47B | 9.28B | 7.10B |
| Operating Cash Flow | 9.41B | 7.57B | 17.36B | 23.52B | 15.90B | 13.25B |
| Investing Cash Flow | -11.43B | -11.37B | -9.55B | -4.77B | -6.39B | -3.64B |
| Financing Cash Flow | 2.55B | 5.77B | -6.67B | -17.98B | -6.74B | -8.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $57.23B | 9.17 | 6.56% | 7.23% | -7.08% | -38.11% | |
74 Outperform | €46.08B | 6.87 | 4.00% | 6.45% | 0.49% | -45.70% | |
70 Outperform | €46.08B | 6.96 | 4.00% | 6.32% | 0.49% | -45.70% | |
65 Neutral | €27.00B | 11.10 | 10.04% | 5.29% | -10.34% | -31.23% | |
63 Neutral | €47.37B | 8.05 | 7.63% | 5.30% | -8.40% | -11.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | €10.62B | -0.49 | -47.46% | 5.12% | -54.23% | -543.31% |